Demonstrates enhanced hydrogen production in E. coli using a peptide-MXene hydrogel, indicating a new bioelectrochemical platform.
Escherichia coli is a compelling target for bioelectrochemical engineering due to its exceptionally well‐established capabilities for recombinant enzyme expression. Yet, a central limitation is the lack of stable and efficient electron delivery to intracellular enzymes, as E. coli lacks native extracellular electron uptake pathways. Thus, programmable intracellular catalysis can be realized, provided efficient electron delivery is achieved. Here, we demonstrate a strategy that supports sustained bioelectrochemical hydrogen (H 2 ) production by E. coli expressing a recombinant algal Ferredoxin‐[FeFe]‐hydrogenase fusion protein. Bacterial cells are immobilized within a self‐assembling peptide hydrogel incorporating the conductive Ti 3 C 2 T z MXene, forming a stable, electroactive biohybrid interface on carbon felt electrodes. The peptide‐MXene hydrogel supports high and stable currents, sustained H 2 generation, and improved residual enzymatic activity during prolonged operation. Structural, mechanical, and metabolic analyses indicate that MXene reinforces the peptide matrix without compromising bacterial viability, enhancing electrode integrity and electronic coupling. Together, these results establish a proof of concept for a broadly applicable bioelectrochemical platform that enables electrode‐microbe coupling in E. coli via a materials‐based approach, thereby circumventing the need for genetically engineered exoelectrogenicity. This strategy enables electron delivery to non‐native intracellular redox enzymes and provides a foundation for coupling electrochemical energy input to engineered metabolic pathways.
No takes yet. Share an insight, caveat, or question.
Ben‐Zvi et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: